title: Apoptosis-resistant mitochondria in T cells selected for resistance to Fas signaling.
abstract: Jurkat leukemic T cells are highly sensitive to the extrinsic pathways of apoptosis induced via the death receptor Fas or tumor necrosis factor-related apoptosis-inducing ligand as well as to the intrinsic/mitochondrial pathways of death induced by VP-16 or staurosporin. We report here that clonal Jurkat cell lines selected for resistance to Fas-induced apoptosis were cross-resistant to VP-16 or staurosporin. Each of the apoptotic pathways was blocked at an apical phase, where common regulators of apoptosis have not yet been defined. The Fas pathway was blocked at the level of caspase-8, whereas the intrinsic pathway was blocked at the mitochondria. No processing or activity of caspases was detected in resistant cells in response to either Fas-cross-linking or VP-16 treatment. Also, no apoptosis-associated alterations in the mitochondrial inner membrane, outer membrane, or matrix were detected in resistant Jurkat cells treated with VP-16. Thus, no changes in permeability transition, loss in inner membrane cardiolipin, generation of reactive oxygen species, or release of cytochrome c were observed in resistant cells treated with VP-16. Further, unlike purified mitochondria from wild type cells, those obtained from resistant cells did not release cytochrome c or apoptosis-inducing factor in response to recombinant Bax or truncated Bid. These results identify a defect in mitochondria ability to release intermembrane proteins in response to Bid or Bax as a mechanism of resistance to chemotherapeuetic drugs. Further, the selection of VP-16-resistant mitochondria via elimination of Fas-susceptible cells may suggest the existence of a shared regulatory component between the extrinsic and intrinsic pathways of apoptosis.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
authors.forename: G Q
authors.initials: GQ
authors.lastname: Wang
authors.forename: B R
authors.initials: BR
authors.lastname: Gastman
authors.forename: E
authors.initials: E
authors.lastname: Wieckowski
authors.forename: L A
authors.initials: LA
authors.lastname: Goldstein
authors.forename: A
authors.initials: A
authors.lastname: Rabinovitz
authors.forename: X M
authors.initials: XM
authors.lastname: Yin
authors.forename: H
authors.initials: H
authors.lastname: Rabinowich
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000502:physiology*; D020169:Caspases / Q000378:metabolism; D004789:Enzyme Activation; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D008928:Mitochondria / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D016176:T-Lymphocyte Subsets / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D013601:T-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000276:immunology* / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D019014:fas Receptor; D005047:Etoposide; D020169:Caspases